Cargando…

Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer

Detalles Bibliográficos
Autores principales: Chen, Minting, Zhong, Keying, Tan, Jincheng, Meng, Mingjing, Liu, Chok Mei, Chen, Baisen, Huang, Chunhua, Wong, Hoi Leong Xavier, Bian, Zhaoxiang, Su, Tao, Kwan, Hiu Yee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567042/
https://www.ncbi.nlm.nih.gov/pubmed/34841696
http://dx.doi.org/10.1002/ctm2.564
_version_ 1784594149512577024
author Chen, Minting
Zhong, Keying
Tan, Jincheng
Meng, Mingjing
Liu, Chok Mei
Chen, Baisen
Huang, Chunhua
Wong, Hoi Leong Xavier
Bian, Zhaoxiang
Su, Tao
Kwan, Hiu Yee
author_facet Chen, Minting
Zhong, Keying
Tan, Jincheng
Meng, Mingjing
Liu, Chok Mei
Chen, Baisen
Huang, Chunhua
Wong, Hoi Leong Xavier
Bian, Zhaoxiang
Su, Tao
Kwan, Hiu Yee
author_sort Chen, Minting
collection PubMed
description
format Online
Article
Text
id pubmed-8567042
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85670422021-11-09 Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer Chen, Minting Zhong, Keying Tan, Jincheng Meng, Mingjing Liu, Chok Mei Chen, Baisen Huang, Chunhua Wong, Hoi Leong Xavier Bian, Zhaoxiang Su, Tao Kwan, Hiu Yee Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-11-04 /pmc/articles/PMC8567042/ /pubmed/34841696 http://dx.doi.org/10.1002/ctm2.564 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Chen, Minting
Zhong, Keying
Tan, Jincheng
Meng, Mingjing
Liu, Chok Mei
Chen, Baisen
Huang, Chunhua
Wong, Hoi Leong Xavier
Bian, Zhaoxiang
Su, Tao
Kwan, Hiu Yee
Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer
title Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer
title_full Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer
title_fullStr Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer
title_full_unstemmed Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer
title_short Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer
title_sort baicalein is a novel tlr4‐targeting therapeutics agent that inhibits tlr4/hif‐1α/vegf signaling pathway in colorectal cancer
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567042/
https://www.ncbi.nlm.nih.gov/pubmed/34841696
http://dx.doi.org/10.1002/ctm2.564
work_keys_str_mv AT chenminting baicaleinisanoveltlr4targetingtherapeuticsagentthatinhibitstlr4hif1avegfsignalingpathwayincolorectalcancer
AT zhongkeying baicaleinisanoveltlr4targetingtherapeuticsagentthatinhibitstlr4hif1avegfsignalingpathwayincolorectalcancer
AT tanjincheng baicaleinisanoveltlr4targetingtherapeuticsagentthatinhibitstlr4hif1avegfsignalingpathwayincolorectalcancer
AT mengmingjing baicaleinisanoveltlr4targetingtherapeuticsagentthatinhibitstlr4hif1avegfsignalingpathwayincolorectalcancer
AT liuchokmei baicaleinisanoveltlr4targetingtherapeuticsagentthatinhibitstlr4hif1avegfsignalingpathwayincolorectalcancer
AT chenbaisen baicaleinisanoveltlr4targetingtherapeuticsagentthatinhibitstlr4hif1avegfsignalingpathwayincolorectalcancer
AT huangchunhua baicaleinisanoveltlr4targetingtherapeuticsagentthatinhibitstlr4hif1avegfsignalingpathwayincolorectalcancer
AT wonghoileongxavier baicaleinisanoveltlr4targetingtherapeuticsagentthatinhibitstlr4hif1avegfsignalingpathwayincolorectalcancer
AT bianzhaoxiang baicaleinisanoveltlr4targetingtherapeuticsagentthatinhibitstlr4hif1avegfsignalingpathwayincolorectalcancer
AT sutao baicaleinisanoveltlr4targetingtherapeuticsagentthatinhibitstlr4hif1avegfsignalingpathwayincolorectalcancer
AT kwanhiuyee baicaleinisanoveltlr4targetingtherapeuticsagentthatinhibitstlr4hif1avegfsignalingpathwayincolorectalcancer